Cardiovascular Disease Diagnostics Solutions

Successful management of cardiovascular diseases means mitigating adverse events by making the right decisions. Clinicians want to diagnose and initiate appropriate treatment quickly to improve patient outcomes.

Cardiovascular diseases account for an estimated 31% of all deaths worldwide and are the number one cause of death globally, killing ~17.9 million people each year. Four out of five cardiovascular diseases deaths are due to heart attacks and strokes, and one third of these deaths occur prematurely in people under 70 years of age¹. The annual global cost of cardiovascular diseases is estimated to rise to $1,044 billion USD by 2030² .

Clinical laboratories can improve care for patients experiencing, or at risk for, cardiovascular disease. The speed and accuracy of the information your laboratory delivers are critical to improving patient outcomes and reducing the cost of care.

Beckman Coulter's comprehensive cardiac diagnostics menu provides the tests your laboratory needs to support informed clinical decision making.

Natriuretic peptides are proteins secreted by the heart in response to volume or pressure overload. They are important biomarkers in the diagnosis of heart failure.³ Achieve greater clinical insights to improve the management of heart failure patients across the disease spectrum from diagnosis to risk stratification and ongoing assessments of severity with Beckman Coulter’s Access BNP and Access NT-proBNP.

Learn more about Access BNP and Access NT-proBNP › 

Confidently report accurate results with the first true high-sensitivity troponin I assay cleared by the U.S. FDA. High-sensitivity troponin tests support more rapid decision making, which can help detect, triage and manage at-risk patients sooner⁴ and send acute myocardial infarction (AMI) low risk patients home faster.⁵

Learn how high-sensitivity troponin assays can improve patient outcomes ›

Access hsTnI detects circulating Troponin I, a protein released into circulation when there is damage to heart muscle cells. hsTnI tests are primarily used to help determine if an individual has suffered a heart attack (acute myocardial infarction). hsTnI tests detect Troponin I quantities sooner, which helps give clinicians important insights into life-threatening cardiac conditions in patients presenting with chest pains faster.

Learn more about Access hsTnI ›

Let us help you enhance your laboratory to support your patients' cardiovascular health management needs today and tomorrow. Contact us to get started.